Yumeng Bao

Phospholipid-modified glycogen nanoparticles for synergistic chemo-photothermal treatment of glioblastoma.

Glioblastoma multiforme (GBM) remains one of the most aggressive central nervous system malignancies, with therapeutic efficacy severely constrained by the blood-brain barrier (BBB), which limits drug delivery to the tumor site, and by the lack of tumor-specific targeting, leading to off-target effects and inadequate i...